These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17490913)

  • 1. Second-generation endometrial ablation treatment: Novasure.
    Bongers MY
    Best Pract Res Clin Obstet Gynaecol; 2007 Dec; 21(6):989-94. PubMed ID: 17490913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year follow up of a randomised controlled trial comparing NovaSure and ThermaChoice endometrial ablation.
    Kleijn JH; Engels R; Bourdrez P; Mol BW; Bongers MY
    BJOG; 2008 Jan; 115(2):193-8. PubMed ID: 17617188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NovaSure impedance controlled system for endometrial ablation: three-year follow-up on 107 patients.
    Gallinat A
    Am J Obstet Gynecol; 2004 Nov; 191(5):1585-9. PubMed ID: 15547528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial ablation with NovaSure GEA, a pilot study.
    Busund B; Erno LE; Grønmark A; Istre O
    Acta Obstet Gynecol Scand; 2003 Jan; 82(1):65-8. PubMed ID: 12580843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trial of bipolar radio-frequency endometrial ablation and balloon endometrial ablation.
    Bongers MY; Bourdrez P; Mol BW; Heintz AP; Brölmann HA
    BJOG; 2004 Oct; 111(10):1095-102. PubMed ID: 15383112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An impedance-controlled system for endometrial ablation: five-year follow-up of 107 patients.
    Gallinat A
    J Reprod Med; 2007 Jun; 52(6):467-72. PubMed ID: 17694962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the NovaSure Impedance Controlled Endometrial Ablation System in patients with intracavitary disease: 12-month follow-up results of a prospective, single-arm clinical study.
    Sabbah R; Desaulniers G
    J Minim Invasive Gynecol; 2006; 13(5):467-71. PubMed ID: 16962534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermoregulated radiofrequency endometrial ablation.
    Dequesne JH; Gallinat A; Garza-Leal JG; Sutton CJ; van der Pas HF; Wamsteker K; Chandler JG
    Int J Fertil Womens Med; 1997; 42(5):311-8. PubMed ID: 9406837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NovaSure impedance controlled endometrial ablation: long-term follow-up results.
    Fulop T; Rákóczi I; Barna I
    J Minim Invasive Gynecol; 2007; 14(1):85-90. PubMed ID: 17218236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health technology assessment of surgical therapies for benign gynaecological disease.
    Owusu-Ansah R; Gatongi D; Chien PF
    Best Pract Res Clin Obstet Gynaecol; 2006 Dec; 20(6):841-79. PubMed ID: 17145485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New endometrial ablation techniques for treatment of menorrhagia.
    Bradley LD
    Surg Technol Int; 2004; 12():161-70. PubMed ID: 15455321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia.
    Cooper J; Gimpelson R; Laberge P; Galen D; Garza-Leal JG; Scott J; Leyland N; Martyn P; Liu J
    J Am Assoc Gynecol Laparosc; 2002 Nov; 9(4):418-28. PubMed ID: 12386350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective observational study of Thermablate Endometrial Ablation System as an outpatient procedure.
    Prasad P; Powell MC
    J Minim Invasive Gynecol; 2008; 15(4):476-9. PubMed ID: 18602047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and comparison of intraoperative and postoperative pain associated with NovaSure and ThermaChoice endometrial ablation systems.
    Laberge PY; Sabbah R; Fortin C; Gallinat A
    J Am Assoc Gynecol Laparosc; 2003 May; 10(2):223-32. PubMed ID: 12732777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summary of safety and effectiveness data from FDA: a valuable source of information on the performance of global endometrial ablation devices.
    Cooper J; Gimpelson RJ
    J Reprod Med; 2004 Apr; 49(4):267-73. PubMed ID: 15134151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NovaSure bipolar radiofrequency endometrial ablation: report of 200 cases.
    Baskett TF; Clough H; Scott TA
    J Obstet Gynaecol Can; 2005 May; 27(5):473-6. PubMed ID: 16100642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global endometrial ablation for menorrhagia in women with bleeding disorders.
    El-Nashar SA; Hopkins MR; Feitoza SS; Pruthi RK; Barnes SA; Gebhart JB; Cliby WA; Famuyide AO
    Obstet Gynecol; 2007 Jun; 109(6):1381-7. PubMed ID: 17540811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novasure impedance control system versus microwave endometrial ablation for the treatment of dysfunctional uterine bleeding: a double-blind, randomized controlled trial.
    Athanatos D; Pados G; Venetis CA; Stamatopoulos P; Rousso D; Tsolakidis D; Stamatopoulos CP; Tarlatzis BC
    Clin Exp Obstet Gynecol; 2015; 42(3):347-51. PubMed ID: 26152008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology of the NovaSure (radio-frequency) impedance-controlled endometrial ablation system.
    Fadare O; Qin L; Martel M; Tavassoli FA
    Arch Pathol Lab Med; 2005 Sep; 129(9):1175-8. PubMed ID: 16119995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-year follow-up of endometrial ablation.
    Fürst SN; Philipsen T; Joergensen JC
    Acta Obstet Gynecol Scand; 2007; 86(3):334-8. PubMed ID: 17364309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.